A report in the journal Science from researchers in the UW–Madison Department of Chemistry represents a significant advance in making the types of molecules needed in drug development. Molecules with three-dimensional complexity are known to be better for drug development than flatter molecules, but accessing molecular complexity has historically been challenging. The work in this paper sets the stage for addressing this long-standing problem.